Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma

NCT06933836 is registered in ClinicalTrials.gov with Barnet Dulaney Perkins Eye Centers as lead sponsor.

NCT NCT06933836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06933836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma
Lead sponsor
Barnet Dulaney Perkins Eye Centers
Phase
Observational
Overall status
Recruiting
Start date
March 31, 2025
Completion date
December 31, 2027
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

open angle glaucoma (oag)